Fosun International Ltd. is considering a bid for Bayer AG’s animal-health business, people familiar with the matter said, a move that would allow the Chinese conglomerate to tap into the growing market of treatments for pets and livestock.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
